Valthos builds next-generation biodefense.
Valthos has raised $30.0M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
Valthos's investors include OpenAI, Founders Fund, Lux Capital.
Valthos is headquartered in New York, United States.
Valthos builds next-generation biodefense.
Valthos is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Valthos — Funding & Investors." VCBacked, October 24, 2025, https://www.vcbacked.co/company/valthos. Accessed July 19, 2026.
VCBacked. (2025). Valthos — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/valthos
{{cite web |title=Valthos — Funding & Investors |url=https://www.vcbacked.co/company/valthos |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated